Poly-L-lactic acid injections may improve facial lipoatrophy among patients with HIV infection. This randomized trial examines the safety and efficacy of these injections for facial lipoatrophy. JAIDS: Journal of Acquired Immune Deficiency Syndromes
Alefacept, which in 2003 was the first biologic agent approved in the US for the treatment of moderate to severe chronic plaque psoriasis, appears to be a long-term option for certain patients. Reuters Health Information
Findings from a small study indicate that dapsone may be of help in reducing steroid dependence in certain patients with pemphigus vulgaris, researchers report in the January issue of the Archives of Dermatology. Reuters Health Information
An ongoing FDA safety review of Botox, Botox Cosmetic (botulinum toxin type A), and Myobloc (botulinum toxin type B) has shown systemic adverse reactions resembling botulism. Medscape Medical News
A single clinical team working from distinctly different hospital based wound programs achieve consistent outcomes using a uniform clinical approach to wound care Wounds
